Clomethiazole

DB06470

small molecule investigational

Deskripsi

Clomethiazole is a well-established ?-aminobutyric acid (GABAA)-mimetic drug. It is a sedative and hypnotic that is widely used in treating and preventing symptoms of acute alcohol withdrawal. It is a drug which is structurally related to thiamine (vitamin B1) but acts like a sedative, hypnotic, muscle relaxant and anticonvulsant. It is also used for the management of agitation, restlessness, short-term insomnia and Parkinson's disease in the elderly.

Struktur Molekul 2D

Berat 161.65
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

989 Data
Buprenorphine Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.
Hydrocodone Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.
Magnesium sulfate The therapeutic efficacy of Clomethiazole can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Clomethiazole may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.
Mirtazapine Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.
Orphenadrine Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.
Pramipexole Clomethiazole may increase the sedative activities of Pramipexole.
Ropinirole Clomethiazole may increase the sedative activities of Ropinirole.
Rotigotine Clomethiazole may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Clomethiazole.
Suvorexant Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.
Thalidomide Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Mefloquine The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Mefloquine.
Mianserin The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Mianserin.
Orlistat Orlistat can cause a decrease in the absorption of Clomethiazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Topotecan Clomethiazole may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.
Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Clomethiazole.
Sodium oxybate Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Tetracosactide The risk or severity of liver damage can be increased when Tetracosactide is combined with Clomethiazole.
Ethanol Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.
Fluvoxamine The risk or severity of adverse effects can be increased when Clomethiazole is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Clomethiazole is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Clomethiazole is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Clomethiazole is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Clomethiazole is combined with Paroxetine.
Sibutramine The risk or severity of adverse effects can be increased when Clomethiazole is combined with Sibutramine.
Escitalopram The risk or severity of adverse effects can be increased when Clomethiazole is combined with Escitalopram.
Zimelidine The risk or severity of adverse effects can be increased when Clomethiazole is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Clomethiazole is combined with Dapoxetine.
Milnacipran The risk or severity of adverse effects can be increased when Clomethiazole is combined with Milnacipran.
Desvenlafaxine The risk or severity of adverse effects can be increased when Clomethiazole is combined with Desvenlafaxine.
Seproxetine The risk or severity of adverse effects can be increased when Clomethiazole is combined with Seproxetine.
Indalpine The risk or severity of adverse effects can be increased when Clomethiazole is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Clomethiazole is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Clomethiazole is combined with Alaproclate.
Cyproheptadine The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Clomethiazole.
Amoxapine The risk or severity of CNS depression can be increased when Amoxapine is combined with Clomethiazole.
Propiomazine The risk or severity of CNS depression can be increased when Propiomazine is combined with Clomethiazole.
Cocaine The risk or severity of methemoglobinemia can be increased when Clomethiazole is combined with Cocaine.
Maprotiline The risk or severity of CNS depression can be increased when Maprotiline is combined with Clomethiazole.
Pizotifen The risk or severity of CNS depression can be increased when Pizotifen is combined with Clomethiazole.
Doxepin The risk or severity of CNS depression can be increased when Doxepin is combined with Clomethiazole.
Quetiapine The risk or severity of CNS depression can be increased when Quetiapine is combined with Clomethiazole.
Nortriptyline The risk or severity of CNS depression can be increased when Nortriptyline is combined with Clomethiazole.
Amitriptyline The risk or severity of CNS depression can be increased when Amitriptyline is combined with Clomethiazole.
Imipramine The risk or severity of CNS depression can be increased when Imipramine is combined with Clomethiazole.
Desipramine The risk or severity of CNS depression can be increased when Desipramine is combined with Clomethiazole.
Nicardipine The metabolism of Clomethiazole can be decreased when combined with Nicardipine.
Quinidine The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Quinidine.
Zopiclone The risk or severity of adverse effects can be increased when Clomethiazole is combined with Zopiclone.
Botulinum toxin type B The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Clomethiazole.
Botulinum toxin type A The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Clomethiazole.
Tryptophan The risk or severity of CNS depression can be increased when Tryptophan is combined with Clomethiazole.
Baclofen Baclofen may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.
Lorazepam The risk or severity of CNS depression can be increased when Lorazepam is combined with Clomethiazole.
Ethchlorvynol The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Clomethiazole.
Succinylcholine The risk or severity of CNS depression can be increased when Succinylcholine is combined with Clomethiazole.
Reserpine The risk or severity of CNS depression can be increased when Reserpine is combined with Clomethiazole.
Enflurane The risk or severity of CNS depression can be increased when Enflurane is combined with Clomethiazole.
Temazepam The risk or severity of CNS depression can be increased when Temazepam is combined with Clomethiazole.
Reboxetine The risk or severity of CNS depression can be increased when Reboxetine is combined with Clomethiazole.
Butabarbital The risk or severity of CNS depression can be increased when Butabarbital is combined with Clomethiazole.
Butalbital The risk or severity of CNS depression can be increased when Butalbital is combined with Clomethiazole.
Cabergoline The risk or severity of CNS depression can be increased when Cabergoline is combined with Clomethiazole.
Topiramate The risk or severity of CNS depression can be increased when Topiramate is combined with Clomethiazole.
Clemastine The risk or severity of CNS depression can be increased when Clemastine is combined with Clomethiazole.
Venlafaxine The risk or severity of CNS depression can be increased when Venlafaxine is combined with Clomethiazole.
Etomidate The risk or severity of CNS depression can be increased when Etomidate is combined with Clomethiazole.
Morphine The risk or severity of CNS depression can be increased when Morphine is combined with Clomethiazole.
Talbutal The risk or severity of CNS depression can be increased when Talbutal is combined with Clomethiazole.
Valproic acid The risk or severity of CNS depression can be increased when Valproic acid is combined with Clomethiazole.
Zolmitriptan The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Clomethiazole.
Codeine The risk or severity of CNS depression can be increased when Codeine is combined with Clomethiazole.
Tolcapone The risk or severity of CNS depression can be increased when Tolcapone is combined with Clomethiazole.
Hydromorphone The risk or severity of CNS depression can be increased when Hydromorphone is combined with Clomethiazole.
Olanzapine The risk or severity of CNS depression can be increased when Olanzapine is combined with Clomethiazole.
Cetirizine The risk or severity of CNS depression can be increased when Cetirizine is combined with Clomethiazole.
Protriptyline The risk or severity of CNS depression can be increased when Protriptyline is combined with Clomethiazole.
Trimethadione The risk or severity of CNS depression can be increased when Trimethadione is combined with Clomethiazole.
Clobazam The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Clomethiazole.
Chlorzoxazone The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Clomethiazole.
Clozapine The metabolism of Clomethiazole can be decreased when combined with Clozapine.
Meprobamate The risk or severity of CNS depression can be increased when Meprobamate is combined with Clomethiazole.
Thiethylperazine The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Clomethiazole.
Palonosetron The risk or severity of CNS depression can be increased when Palonosetron is combined with Clomethiazole.
Sulpiride The risk or severity of CNS depression can be increased when Sulpiride is combined with Clomethiazole.
Dexbrompheniramine The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Clomethiazole.

Target Protein

Gamma-aminobutyric acid receptor subunit gamma-3 GABRG3
Gamma-aminobutyric acid receptor subunit alpha-1 GABRA1

Referensi & Sumber

Artikel (PubMed)
  • PMID: 17895123
    Lyden PD, Ashwood T, Claesson L, Odergren T, Friday GH, Martin-Munley S: The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada. J Stroke Cerebrovasc Dis. 1998 Nov-Dec;7(6):435-41.
  • PMID: 17321821
    Millis SR, Straube D, Iramaneerat C, Smith EV Jr, Lyden P: Measurement properties of the National Institutes of Health Stroke Scale for people with right- and left-hemisphere lesions: further analysis of the clomethiazole for acute stroke study-ischemic (class-I) trial. Arch Phys Med Rehabil. 2007 Mar;88(3):302-8.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Zendra

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul